Zydus Lifesciences Limited Share Price & Technical Analysis
ZYDUSLIFE · ₹1,079 (+0.57%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹1,079
+0.57%
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Consumer Products. It offers active pharmaceutical ingredients, finished dosage formulations, generics, specialty, biosimilars, vaccines, novel products, cons…
Price chart
Seasonality
May has 4 positive and 1 negative years (last 5 years shown)
21% return in May, 2% avg return in past 3 year May month.
20% return in 2026, 23% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -4% | 5% | -3% | 0% | 21% | – | – | – | – | – | – | – | 20% |
| 25 | 0% | -10% | 1% | 0% | 5% | 6% | -3% | 1% | -1% | -1% | -3% | -3% | -7% |
| 24 | 11% | 23% | 6% | -7% | 4% | 3% | 14% | -10% | -5% | -7% | -4% | 1% | 28% |
| 23 | 3% | 7% | 5% | 4% | -3% | 16% | 8% | -1% | -2% | -7% | 11% | 7% | 48% |
| 22 | -16% | -12% | -2% | 0% | 8% | -4% | -3% | 9% | 2% | 11% | -6% | 2% | -11% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Strong
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Consumer Products. It offers active pharmaceutical ingredients, finished dosage formulations, generics, specialty, biosimilars, vaccines, novel products, consumer wellness and animal health products under the Everyuth, Nutralite, SugarFree, Complan, Glucon-D, and Nycil brands. The company also provides a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology, and infectious illnesses, as well as in the therapeutic areas of pain management, neurology, metabolic disorder, and neurology. In addition, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. Further, it develops and markets products for orthopaedic surgery, including pathologies affecting the hip and knee. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is headquartered in Ahmedabad, India. Zydus Lifesciences Limited is a subsidiary of Zydus Family Trust.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹936.45B
P/E ratio
18.96
52W high
₹1,094
52W low
₹835.5
Volume
19,47,685
Beta
0.32
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,260
Frequently asked questions
- What is Zydus Lifesciences Limited share price today?
- Zydus Lifesciences Limited (ZYDUSLIFE) last traded around ₹1,079 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ZYDUSLIFE have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ZYDUSLIFE. Download the app for real-time alerts.
- How can I analyze Zydus Lifesciences Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.